Figure 2From: Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatinTumor suppression and survival advantage in C57BL/6 mice bearing LLC. Tumor volume(A) and survival curves(B). Each group of Mice bearing LLC was s.c. injected intratumorally with corresponding treatment as described in "Methods". Treatment with combination of cisplatin and Ad-Endo resulted in the marked inhibition of tumor growth and longer life span(P < 0.05).Back to article page